2776 - 2800 of 6078 Results
Title
Year
- A LRRK2 GTP Binding Inhibitor, 68, Reduces LPS-Induced Signaling Events and TNF-α Release in Human Lymphoblasts2021OPENTitle: A LRRK2 GTP Binding Inhibitor, 68, Reduces LPS-Induced Signaling Events and TNF-α Release in Human LymphoblastsJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 2Start Page: 480End Page: 480Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10020480Best OA location URL: https://www.mdpi.com/2073-4409/10/2/480/pdf?version=1614234637Citation Count: 19
- The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease2021OPENTitle: The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 153Issue #:Start Page: 105312End Page: 105312Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105312Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105312Citation Count: 50
-
OPENTitle: A Novel SNCA A30G Mutation Causes Familial Parkinsonʼs DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1624End Page: 1633Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28534Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28534Citation Count: 86
-
OPENTitle: Am I My Cousin's Keeper? A Proposal to Protect Relatives of Genetic Database SubjectsJournal Name: Indiana Health Law ReviewPublisher: IUPUI University LibraryVol: 18Issue #: 1Start Page: 1End Page: 55Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18060/25052Best OA location URL: https://journals.iupui.edu/index.php/ihlr/article/download/25052/23545Citation Count: 3
-
OPENTitle: Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2539End Page: 2548Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28533Citation Count: 47
-
OPENTitle: Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer DiseaseJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 80Issue #: 3Start Page: 240End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlaa160Best OA location URL: https://academic.oup.com/jnen/article-pdf/80/3/240/36335359/nlaa160.pdfCitation Count: 20
-
OPENTitle: β‐Blocker–Induced TremorJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 3Start Page: 449End Page: 452Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13176Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13176Citation Count: 4
- Distinct neural circuits are associated with subclinical neuropsychiatric symptoms in Parkinson's disease2021OPENTitle: Distinct neural circuits are associated with subclinical neuropsychiatric symptoms in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 423Issue #:Start Page: 117365End Page: 117365Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2021.117365Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009831Citation Count: 18
- Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit2021OPENTitle: Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficitJournal Name: MedicinePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 100Issue #: 7Start Page: e24837End Page: e24837Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1097/md.0000000000024837Best OA location URL: https://doi.org/10.1097/md.0000000000024837Citation Count: 14
- LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo2021OPENTitle: LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In VivoJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 949End Page: 961Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-021-01007-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01007-8.pdfCitation Count: 12
- Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study2021OPENTitle: Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 203End Page: 212Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30449-xBest OA location URL: http://hdl.handle.net/20.500.11820/2546dc5d-292d-400c-a98d-20dd5d9c5621Citation Count: 250
- Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson’s disease cohort2021OPENTitle: Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson’s disease cohortJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 30Issue #: 6Start Page: 454End Page: 466Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddab058Best OA location URL: https://academic.oup.com/hmg/article-pdf/30/6/454/37875911/ddab058.pdfCitation Count: 28
- Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial2021OPENTitle: Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 182End Page: 192Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30489-0Best OA location URL: http://www.thelancet.com/article/S1474442220304890/pdfCitation Count: 103
-
OPENTitle: A 2-Pyridone Amide Inhibitor of Transcriptional Activity in Chlamydia trachomatisJournal Name: Antimicrobial Agents and ChemotherapyPublisher: American Society for MicrobiologyVol: 65Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1128/aac.01826-20Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092867Citation Count: 5
- PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data2021OPENTitle: PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic dataJournal Name: MicrobiomePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40168-020-00993-9Best OA location URL: https://microbiomejournal.biomedcentral.com/track/pdf/10.1186/s40168-020-00993-9Citation Count: 132
-
OPENTitle: Investigating ELOVL7 coding variants in multiple system atrophyJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 749Issue #:Start Page: 135723End Page: 135723Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neulet.2021.135723Best OA location URL: http://manuscript.elsevier.com/S0304394021001014/pdf/S0304394021001014.pdfCitation Count: 2
-
OPENTitle: Genetic background influences LRRK2-mediated Rab phosphorylation in the rat brainJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1759Issue #:Start Page: 147372End Page: 147372Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2021.147372Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006086Citation Count: 9
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture2021OPENTitle: Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architectureJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 3Start Page: 294End Page: 303Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-021-00785-3Best OA location URL: https://nottingham-repository.worktribe.com/preview/5054903/LBD_manuscript_revision.pdfCitation Count: 276
-
OPENTitle: Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 4Start Page: 534End Page: 540Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13168Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13168Citation Count: 20
- Non‐Motor Fluctuations in Parkinson's Disease: Validation of the Non‐Motor Fluctuation Assessment Questionnaire2021OPENTitle: Non‐Motor Fluctuations in Parkinson's Disease: Validation of the Non‐Motor Fluctuation Assessment QuestionnaireJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1392End Page: 1400Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28507Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/168292/2/mds28507_am.pdfCitation Count: 33
- Objective screening for olfactory and gustatory dysfunction during the COVID‐19 pandemic: A prospective study in healthcare workers using self‐administered testing2021OPENTitle: Objective screening for olfactory and gustatory dysfunction during the COVID‐19 pandemic: A prospective study in healthcare workers using self‐administered testingJournal Name: World Journal of Otorhinolaryngology - Head and Neck SurgeryPublisher: WileyVol: 8Issue #: 3Start Page: 249End Page: 256Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.wjorl.2021.02.001Best OA location URL: https://doi.org/10.1016/j.wjorl.2021.02.001Citation Count: 31
- Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiency2021OPENTitle: Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiencyJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 87Issue #: 9Start Page: 3608End Page: 3618Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bcp.14777Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.14777Citation Count: 15
-
OPENTitle: Single-Cell Imaging for Studies of Renal Uranium Transport and Intracellular BehaviorJournal Name: MineralsPublisher: MDPI AGVol: 11Issue #: 2Start Page: 191End Page: 191Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/min11020191Best OA location URL: https://www.mdpi.com/2075-163X/11/2/191/pdf?version=1614237642Citation Count: 6
-
OPENTitle: Validating Differential Volatilome Profiles in Parkinson’s DiseaseJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 2Start Page: 300End Page: 306Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acscentsci.0c01028Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/231972/231972.pdfCitation Count: 30
- Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease2021OPENTitle: Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1451End Page: 1455Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28525Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28525Citation Count: 21